143 related articles for article (PubMed ID: 16891027)
1. A polymeric micelle MRI contrast agent with changeable relaxivity.
Nakamura E; Makino K; Okano T; Yamamoto T; Yokoyama M
J Control Release; 2006 Sep; 114(3):325-33. PubMed ID: 16891027
[TBL] [Abstract][Full Text] [Related]
2. Gd-DTPA-loaded polymer-metal complex micelles with high relaxivity for MR cancer imaging.
Mi P; Cabral H; Kokuryo D; Rafi M; Terada Y; Aoki I; Saga T; Takehiko I; Nishiyama N; Kataoka K
Biomaterials; 2013 Jan; 34(2):492-500. PubMed ID: 23059004
[TBL] [Abstract][Full Text] [Related]
3. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
Rowe MD; Chang CC; Thamm DH; Kraft SL; Harmon JF; Vogt AP; Sumerlin BS; Boyes SG
Langmuir; 2009 Aug; 25(16):9487-99. PubMed ID: 19422256
[TBL] [Abstract][Full Text] [Related]
4. Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics.
Shiraishi K; Kawano K; Maitani Y; Yokoyama M
J Control Release; 2010 Dec; 148(2):160-7. PubMed ID: 20804796
[TBL] [Abstract][Full Text] [Related]
5. Micelles derivatized with octreotide as potential target-selective contrast agents in MRI.
Morisco A; Accardo A; Gianolio E; Tesauro D; Benedetti E; Morelli G
J Pept Sci; 2009 Mar; 15(3):242-50. PubMed ID: 19035577
[TBL] [Abstract][Full Text] [Related]
6. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a tartaric acid derived polymeric MRI contrast agent to a small molecule model chelate.
Lucas RL; Benjamin M; Reineke TM
Bioconjug Chem; 2008 Jan; 19(1):24-7. PubMed ID: 18092744
[TBL] [Abstract][Full Text] [Related]
9. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
10. Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors.
Mi P; Kokuryo D; Cabral H; Kumagai M; Nomoto T; Aoki I; Terada Y; Kishimura A; Nishiyama N; Kataoka K
J Control Release; 2014 Jan; 174():63-71. PubMed ID: 24211705
[TBL] [Abstract][Full Text] [Related]
11. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
[TBL] [Abstract][Full Text] [Related]
12. Probing the interaction of the biotin-avidin complex with the relaxivity of biotinylated Gd-DTPA.
Langereis S; Kooistra HA; van Genderen MH; Meijer EW
Org Biomol Chem; 2004 May; 2(9):1271-3. PubMed ID: 15105914
[TBL] [Abstract][Full Text] [Related]
13. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
[TBL] [Abstract][Full Text] [Related]
14. Diethylenetriaminepentaacetic acid-gadolinium (DTPA-Gd)-conjugated polysuccinimide derivatives as magnetic resonance imaging contrast agents.
Lee HY; Jee HW; Seo SM; Kwak BK; Khang G; Cho SH
Bioconjug Chem; 2006; 17(3):700-6. PubMed ID: 16704207
[TBL] [Abstract][Full Text] [Related]
15. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
[TBL] [Abstract][Full Text] [Related]
16. Calix[4]arenes as molecular platforms for magnetic resonance imaging (MRI) contrast agents.
Schühle DT; Schatz J; Laurent S; Vander Elst L; Muller RN; Stuart MC; Peters JA
Chemistry; 2009; 15(13):3290-6. PubMed ID: 19206118
[TBL] [Abstract][Full Text] [Related]
17. pH-responsive polymeric micelle based on PEG-poly(β-amino ester)/(amido amine) as intelligent vehicle for magnetic resonance imaging in detection of cerebral ischemic area.
Gao GH; Lee JW; Nguyen MK; Im GH; Yang J; Heo H; Jeon P; Park TG; Lee JH; Lee DS
J Control Release; 2011 Oct; 155(1):11-7. PubMed ID: 20854855
[TBL] [Abstract][Full Text] [Related]
18. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]